Progress of research in treatment of hyperlipidemia by monomer or compound recipe of Chinese herbal medicine

Xiao-bing Dou; Xing-de Wo; Chun-lei Fan

doi:10.1007/s11655-008-0071-y

Your Location：

Home >

Browse articles >

Progress of research in treatment of hyperlipidemia by monomer or compound recipe of Chinese herbal medicine

ReviewPaper | Updated：2021-08-27

- Progress of research in treatment of hyperlipidemia by monomer or compound recipe of Chinese herbal medicine
- Progress of research in treatment of hyperlipidemia by monomer or compound recipe of Chinese herbal medicine
- 中国结合医学杂志（英文版） 2008年14卷第1期页码：71-75
- Affiliations：
  
  Zhejiang University of Chinese Medicine,Hangzhou,China
- Author bio：
- Funds：
  
  Supported by the Natural Science Foundation of Zhejiang Province (No. Y204269) and Chinese Medicine Foundation of Zhejiang Province (No. 2005C004)
- DOI：10.1007/s11655-008-0071-y
  中图分类号：
- 纸质出版日期：2008，
  
  网络出版日期：2008-6-21，
Scan for full text
Dou, Xb., Wo, Xd. & Fan, Cl. Progress of research in treatment of hyperlipidemia by monomer or compound recipe of Chinese herbal medicine., Chin. J. Integr. Med. 14, 71–75 (2008). https://doi.org/10.1007/s11655-008-0071-y

Xiao-bing Dou, Xing-de Wo, Chun-lei Fan. Progress of research in treatment of hyperlipidemia by monomer or compound recipe of Chinese herbal medicine[J]. Chinese Journal of Integrative Medicine, 2008,14(1):71-75.
Dou, Xb., Wo, Xd. & Fan, Cl. Progress of research in treatment of hyperlipidemia by monomer or compound recipe of Chinese herbal medicine., Chin. J. Integr. Med. 14, 71–75 (2008). https://doi.org/10.1007/s11655-008-0071-y DOI：

Xiao-bing Dou, Xing-de Wo, Chun-lei Fan. Progress of research in treatment of hyperlipidemia by monomer or compound recipe of Chinese herbal medicine[J]. Chinese Journal of Integrative Medicine, 2008,14(1):71-75. DOI： 10.1007/s11655-008-0071-y.

摘要

Hyperlipidemia (HLP) is the No.1 risk factor for patients with atherosclerosis (AS) and is directly related to the occurrence of coronary artery disease (CAD) and cerebrovascular disease. Therefore

prevention and treatment of AS is of great importance and of practical significance in controlling the incidence and mortality of CAD. With its peculiar syndrome-dependent therapy

traditional Chinese medicine (TCM) has accumulated abundant practical experiences in this field and good clinical effects have been achieved. Chinese herbal medicine

with its particularly unique advantages and high potentials yet to be tapped

displays its huge strength in HLP prevention and treatment. The progress of studies concerning prevention and treatment of HLP by Chinese herbal medicines

in the form of monomers or compound recipes

is reviewed in this paper.

Abstract

Hyperlipidemia (HLP) is the No.1 risk factor for patients with atherosclerosis (AS) and is directly related to the occurrence of coronary artery disease (CAD) and cerebrovascular disease. Therefore

prevention and treatment of AS is of great importance and of practical significance in controlling the incidence and mortality of CAD. With its peculiar syndrome-dependent therapy

traditional Chinese medicine (TCM) has accumulated abundant practical experiences in this field and good clinical effects have been achieved. Chinese herbal medicine

with its particularly unique advantages and high potentials yet to be tapped

displays its huge strength in HLP prevention and treatment. The progress of studies concerning prevention and treatment of HLP by Chinese herbal medicines

in the form of monomers or compound recipes

is reviewed in this paper.

关键词

hyperlipemiaChinese Herbal Medicinemonomercompound recipeprogress of study

Keywords

hyperlipemiaChinese Herbal Medicinemonomercompound recipeprogress of study

references

Wang MR, Han MX. Advances in researches on visceral pathogenesis of hyperlipidemia. Chin J Basic Med Tradit Chin Med (Chin) 2005;11(4):316–319.

Sun LY, Jiao YB, Kang GS. Study developing of hyperlipemia in etological factor and pathological mechanism. Chin J Chin Indigenous Med (Chin) 2004;32(2):70–71.

Liu HY. The study of the cure of traditional Chinese medicine on hyperlipemia. Chin Med Jilin (Chin) 2004;24(8):56–57.

Song JN. Advances in studies on the treatment of atherosclerosis with traditional Chinese medicine. Chin J Basic Med Tradit Chin Med (Chin) 2003;9(11):71–75.

Ye SL, Xie WM, Ding W, et al. Discussion of the mechanism of taditional Chinese mdicine on hyperlipemia. Chin J Integr Med Cardio/Cerebrovas Dis (Chin) 2004; 2(12): 727–729.

Kou WR. The basic and clinic research of Xuezhikang. Chin Prescrip Drug (Chin) 2005;(7):52–57.

Park MY, Lee KS, Sung MK. Effects of dietary mulberry, Korean red ginseng, and banaba on glucose homeostasis in relation to PPAR-alpha, PPAR-gamma, and LPL mRNA expressions. Life Sci 2005;26:3344–3354.

Yan J, Wo XD, Fan CL, et al. Effects of total flavonoids in hawthorn leaves on PPARγ-PPRE pathway regulatory system. Chin Pharm J (Chin) 2005;40(8):625–628.

Wo XD, Cui XQ, Tang LH. Effects of curcumin on the activities of plasma lipase and the concentrations of lipids in hyperlipidemic rats induced by high lipid diet. Chin J Arterioscler (Chin) 2003;11(3): 223–226.

Dou XB, Fan CL, Hong XQ, et al. Effect of curcumin on expression of LDLR in human lymphocytes. Chin Phar J (Chin) 2005;40(13):980–983.

Fan CL, Wo XD, Luo Y, et al. Effect of curcumin on expression of human low-density lipoprotein receptors in Xenopus laevis oocyte. Chin J Integr Tradit West Med (Chin) 2005;25(5):432–435.

Fan CL, Wo XD, Qian Y, et al. Effect of curcumin on the expression of LDL receptor in mouse macrophages. J Ethnopharmacol 2006;105:251–254.

Qian Y, Fan CL, Dou XB, et al. Effect of curcumin on sterol regulating system in HEK-293. Chin Pharm Bull (Chin) 2006;22(7):828–830.

Kong W, Wei J, Abidi P, et al. Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins. Nat Med 2004:1345–1351.

Bursill CA, Roach PD. Modulation of cholesterol metabolism by the green tea polyphenol (-)-epigallocatechin gallate in cultured human liver (HepG2) cells. J Agric Food Chem 2006;54(5):1621–1626.

Ricketts ML, Moore DD, Banz WJ, et al. Molecular mechanisms of action of the soy isoflavones includes activation of promiscuous nuclear receptors. J Nutr Biochem 2005;6:321–330.

Fan CL, Gao LP, Wo XD, et al. Effect of ligustrazine on the human scavenger receptor-AI expressed in Xenopus oocytes. Chin Pharm Bull (Chin) 2005;21(6):746–751.

Niu XL, Ichimori K, Yang X, et al. Tanshinone II-A inhibits low-density lipoprotein oxidation in vitro. Free Radic Res (Chin) 2000;33(3):305–312.

Huo WQ. Study progress in treatment of artherosclerosis with Chinese herbs. Guid J Tradit Chin Med (Chin) 2005;11(11):64–66.

Lu Y. The progress of traditional Chinese medicine on artherosclerosis. Tradit Chin Med Res (Chin) 2005;18(3):61–63.

Chen BJ, Pan ZQ, Su XX. Progression of hyperlipemia treated with integrated traditional Chinese and Western medicine. Modern J Integr Tradit Chin West Med (Chin) 2005;14(21):2882–2884.

Yang H. The study of Chinese herbs on hyperlipemia. Chin J Integr Med Cardio/Cerebrovasc Dis (Chin) 2004;2(1):47–48.

Chen KJ, ed. Pratical internal medicine. Beijing: Union Press of Beijing Medical University & Peking Union Medical College,1999:679–685.

Wo XD, Hong XQ, Zhao GP, et al. Effects of curcumin on the metabolism of low-density lipoprotein and lipoprotein(a). Chin Med News (Chin) 2005;20(22):15–16.

Du BJ, Xu XH, Li LZ. The clinical study of Zhikeping Capsule on hyperlipidemia. Chin J Inf Tradit Chin Med (Chin) 2004;11(9):757–759.

Zhou JQ, Xia XM, Xue ZQ, et al. Effect of Astragalus membranaceus and Radix Salviae miltiorrhizae on low-density lipoprotein receptor in rabbits. Pharmacol Clin Chin Materia Medica (Chin) 2004;20(5):5–7.

Xue ZQ, Guan SJ, Zhang JH, et al. Effect of Qidan Liquid on apolipoprotein of arteriosclerosis rabbits. Chin J Pract Chin Modern Med (Chin) 2004;17(21): 3177–3178.

Yan YH. The preparation and clinic effect of complex prescription of lowering-lipid tea. Prac Clin J Integr Tradit Chin West Med (Chin) 2003;3(2):52–53.

Cai XJ. Observation of Huazhuo Jiangzhi Dcoction in treating 80 patients with hyperlipemia. Shaanxi J Tradit Chin Med (Chin) 2004;25(2): 35–136.

Li YH, Li XC, Zheng HH, et al. Effect of Compound Xuezhiqing modified on reducing fat and anti-atheroscleorsis of rabbits with hyperlipemia. Hubei J Tradit Chin Med (Chin) 2003;25(5):8–10.

Qi CR, Ji SG. Prevention and cure atherosclerosis. Chin J Pract Chin Modern Med (Chin) 2004;17(11):1631–1632.

Han GY, Qi CR. Effects of Tongmai Jiangzhi Decoction on blood lipid and endothelium function of quail with hyperlipemia. Chin J Clin Rehabil (Chin) 2005;9(31):134–135.

Jin ZS, He JC. Influences of Jianpi Jiangzhi Lin on blood lipids in rats with hyperlipemia. Chin J Integr Tradit West Med Intens Crit Care (Chin) 2002;9(1):41–43.

Wang M, Lei GH, Wang Q. Study of the effect of Dancha Capsule in lowering blood lipid. J Chin Med Materia (Chin) 2004;27(9): 671.

Wei W, Huo JL, Zuo YF, et al. The regulating effect of Qishen Jiangzhi on blood lipid. Pharmac Clin Chin Materia Medica (Chin) 2001;17(3):30–31.

Li TC, Zhang H, Zhang FH, et al. Influence of complex prescription Qishenjiangzhiyin on expressions of intercelluar adhesion molecule-1 in the aorta of hypercholesteremia rats. Chin J Clin Pharm (Chin) 2005;14(5):282–284.

Li L, Li ZG. The preparation and clinic observation of compound Zedan Huoxue Jiangzhi Capsule. Lishizhen Med Materiae Medica Res (Chin) 2003;14(11): 676–677.

He SW, He SG, Zhao RH, et al. Effects of the compound purslane on blood lipid, apolipoprotein and hemorheology in patients with hyperlipemia. Chin J Clin Rehabil (Chin) 2005;9(31):164–166.

Liu P, Zhang JS, Zhang XZ. Effects of Guanxin Kang on liver LDLR gene expression in rats with hyperlipemia. Chin Arch Tradit Chin Med (Chin) 2003;21(9):1516–1517.

Tang KX, Wang JG, Wang FB. Effect of Xiongbitong Capsule on gene expression of LDL receptor in rats. Chin J Integr Med Cardio/Cerebrovasc Dis (Chin) 2004;2(8):464–465.

FULL TEXT LINK

More>

浏览量

353

Downloads

CSCD

文章被引用时，请邮件提醒。

Submit

工具集

关联资源

Development is a high level inheritance for China Time-honored Brand products

Effect of Chinese herbal medicine for nourishing yin, supplementing qi, and activating blood on the Th1/Th2 immune balance in peripheral blood in patients with primary Sjogren’s syndrome

Chinese herbal medicine in the treatment of nonalcoholic fatty liver disease

Therapeutic effect of Chinese herbal medicine for strengthening qi, nourishing yin, and removing stasis on serum osteopontin and quality of life of patients with primary Sjogren's syndrome

Effects and mechanisms of actions of Chinese herbal medicines for asthma